Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 3/20 | 0.43 |
| ▸ | ALPI | P09923 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | XIAP | P98170 | 1/20 | 0.43 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.42 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.41 |
| ▸ | NOS3 | P29474 | 1/20 | 0.41 |
| ▸ | NOS1 | P29475 | 1/20 | 0.41 |
| ▸ | NOS2 | P35228 | 1/20 | 0.41 |
| ▸ | TRHDE | Q9UKU6 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | NPY4R | P50391 | 3/20 | 0.40 |
| ▸ | NPY1R | P25929 | 2/20 | 0.40 |
| ▸ | NPY2R | P49146 | 2/20 | 0.40 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenylalanine SCHEMBL18953085 | 1.00 | LTA4H (0.43) | LTA4HALPIPKMPTGS1XIAP | |
| SCHEMBL2585866 | 0.91 | EPHX1 (0.47) | LTA4HEPHX1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL29359776 | 0.91 | EPHX1 (0.47) | LTA4HEPHX1SLC1A3SLC1A2SLC1A1 | |
| Hydrochloric Acid SCHEMBL4087778 | 0.90 | EPHX1 (0.46) | LTA4HEPHX1SLC1A3SLC1A2SLC1A1 | |
| Pabetan SCHEMBL29894618 | 0.87 | NPY4R (0.46) | EPHX1TRHDENPY4RNPY1RNPY2R | |
| Pabetan SCHEMBL21571465 | 0.87 | NPY4R (0.46) | EPHX1TRHDENPY4RNPY1RNPY2R | |
| Pabetan SCHEMBL14928984 | 0.87 | NPY4R (0.46) | EPHX1TRHDENPY4RNPY1RNPY2R | |
| Pabetan SCHEMBL4546522 | 0.87 | NPY4R (0.46) | EPHX1TRHDENPY4RNPY1RNPY2R | |
| Arginine SCHEMBL29067351 | 0.85 | ALPI (0.46) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Arginine SCHEMBL29094092 | 0.84 | ALPI (0.45) | ALPIPKMPTGS1XIAPSLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4326942-A1 | BOOSTED IPBC FOR WET-STATE BACTERIAL CONTROL | Troy Technology II, Inc. (US) | 2024-02-28 | — | — | EP | disclosed |
| CN-117599153-A | Gram-negative bacteria antibiotic sensitizer and application thereof | 武汉大学 | 2024-02-27 | — | — | CN | disclosed |
| CN-117486762-A | Novel compound and use method and application thereof | 中国医学科学院医药生物技术研究所 | 2024-02-02 | — | — | CN | disclosed |
| US-20230357689-A1 | INTRACELLULAR DELIVERY USING MICROFLUIDICS-ASSISTED CELL SCREENING (MACS) | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-11-09 | — | — | US | disclosed |
| US-11634676-B2 | Intracellular delivery using microfluidics-assisted cell screening (MACS) | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-04-25 | — | — | US | disclosed |
| US-20220387610-A1 | PEPTIDE-CONJUGATED PRODRUGS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-12-08 | — | — | US | disclosed |
| US-11382950-B2 | Compositions and methods for cell delivery | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2022-07-12 | — | — | US | disclosed |
| WO-2021055690-A1 | PEPTIDE-CONJUGATED PRODRUGS | BRANDEIS UNIVERSITY (US) | 2021-03-25 | — | — | WO | disclosed |
| US-10640507-B2 | PBD antibacterial agents | KING'S COLLEGE LONDON (GB) | 2020-05-05 | — | — | US | disclosed |
| US-20190275104-A1 | COMPOSITIONS AND METHODS FOR CELL DELIVERY | PIONEERING MEDICINES 08- B, INC. | 2019-09-12 | — | — | US | disclosed |
| WO-2019018497-A1 | INTRACELLULAR DELIVERY USING MICROFLUIDICS-ASSISTED CELL SCREENING (MACS) | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2019-01-24 | — | — | WO | disclosed |
| US-20180354958-A1 | PBD ANTIBACTERIAL AGENTS | Secretary of State for Health and Social Care (GB) | 2018-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10640507-B2 | PBD antibacterial agents | OPRD1, XDH, SBDS | LTA4H 2955/4885ALPI 2074/4885PKM 621/4885 |
| US-20220387610-A1 | PEPTIDE-CONJUGATED PRODRUGS | VIP, DNPEP, PEPD | LTA4H 1299/4885ALPI 844/4885PKM 2381/4885 |
| US-20180354958-A1 | PBD ANTIBACTERIAL AGENTS | OPRD1, XDH, SBDS | LTA4H 2955/4885ALPI 2074/4885PKM 621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.